Introduction {#Sec1}
============

Despite the fact that fluid resuscitation is considered the first line of therapy in hemodynamically unstable patients \[[@CR1]\], a large body of evidence indicates that unnecessary positive fluid balance is associated with increased morbidity and mortality \[[@CR2]-[@CR4]\]. Moreover, conflicting results have been reported with regards to studies investigating goal-directed hemodynamic therapy in critically ill patients, such as Rivers and colleagues' study and the OPTIMISE study \[[@CR5],[@CR6]\]. No matter what the study result is, the first step in hemodynamic therapy in all of the above studies is always preload optimization. However, only about one-half of the critically ill patients exhibit a positive response to fluid challenge \[[@CR7]\], and accurate prediction of fluid responsiveness remains one of the most difficult tasks at the bedside in the ICU.

Medical history, clinical manifestations (such as skin turgor, blood pressure, pulse rate, and urine output), and routine laboratory tests are important but of limited sensitivity and specificity \[[@CR7],[@CR8]\]. Static measures, including central venous pressure, pulmonary capillary wedge pressure, right ventricular end-diastolic volume, left ventricular end-diastolic area, inferior vena-caval diameter, and global end-diastolic volume index, are of poor value in guiding fluid resuscitation \[[@CR1],[@CR7],[@CR9]\].

Over the last decade, a number of studies have been reported, which have used heart--lung interactions during mechanical ventilation to assess fluid responsiveness. Among these functional hemodynamic parameters, pulse pressure variation (PPV) -- which can easily and accurately obtained by online assessment of the arterial waveform with a standard multiparametric monitor \[[@CR10]\] -- has been shown to be highly predictive of fluid responsiveness in a systematic review, with sensitivity, specificity, and diagnostic odds ratio of 0.89, 0.88, and 59.86, respectively \[[@CR11]\]. Nevertheless, seven out of the 29 studies included in the systematic review were performed in operating rooms rather than ICUs. In addition, more studies have been published since. The objective of this systematic review and meta-analysis was to evaluate the accuracy of PPV in predicting fluid responsiveness in ICU patients.

Materials and methods {#Sec2}
=====================

Study selection and inclusion criteria {#Sec3}
--------------------------------------

All relevant clinical trials investigating the ability of PPV to predict fluid responsiveness in adult patients in the ICU were considered for inclusion. Only studies published as full-text articles in an indexed journal were included. Reviews, case reports, and studies published in abstract form were excluded. No language restriction was applied. No ethical approval and patient consent are required.

We included those studies in which the predictive value had been assessed by calculating both sensitivity and specificity in identifying those patients who subsequently responded to fluid challenge. We excluded studies employing a ventilatory strategy that maintained spontaneous breathing or generated a tidal volume \<8 ml/kg. However, those studies without clear statement concerning the presence or absence of spontaneous breathing and tidal volume were included in the final analysis.

Search strategy and data extraction {#Sec4}
-----------------------------------

Two authors independently performed a search in MEDLINE and EMBASE published from inception to 7 May 2014. If discrepancy existed between the two authors, it was resolved by discussion. An advanced search from the EMBASE website was used \[[@CR12]\], with key words of pulse pressure (explode) and fluid responsiveness or fluid challenge or fluid resuscitation (explode). In addition to the electronic search, we checked out cross-references from original articles and reviews.

The two authors independently performed the initial selection by screening titles and abstracts. Citations were selected for further evaluation if the studies they referred to were studies investigating the predictive value of PPV in ICU adult patients. For detailed evaluation, we obtained peer-reviewed full texts of all possibly relevant studies. Data from each study were extracted independently using a standardized form, which included first author, year of publication, sample size, study setting, patient population, primary diagnosis, tidal volume, absence of spontaneous breathing or arrhythmia, type and amount of fluid infused, duration of fluid challenge, definition of responders, instrument(s) used for measuring index, and cardiac output. We also collected data about the method used to measure PPV as well as the threshold of PPV to achieve corresponding sensitivity and specificity. True positive, false positive, false negative, and true negative values were calculated to construct the 2 × 2 contingency table.

When two methods were compared, only the data of the reference method for measuring PPV were included. If data provided in the original study were inadequate to generate the contingency table, we sent two emails, at a 1-week interval, to the corresponding author for clarification. If the author failed to respond to our emails, we excluded the study from the final analysis.

Quality assessment {#Sec5}
------------------

Study quality was assessed using the Quality Assessment of Diagnostic Accuracy included in Systematic Reviews (QUADAS-2) checklist \[[@CR13]\], an improved, redesigned tool based both on experience using the original tool \[[@CR14]\] and new evidence about sources of bias and variation in diagnostic accuracy studies. QUADAS-2 comprised four domains: patient selection, index test, reference standard, and flow and timing. Each domain was assessed in terms of risk of bias, and the first three domains were also assessed in terms of concerns regarding applicability. Each domain was scored as 'yes', 'no', or 'unclear'. We did not calculate summary scores because their interpretation was problematic and potentially misleading \[[@CR15]\].

Statistical analysis {#Sec6}
--------------------

Data were synthesized using an exact binomial rendition of the bivariate mixed-effects regression model modified for synthesis of diagnostic test data \[[@CR16]-[@CR18]\]. Theoretically, bivariate models are motivated and allow estimation of the correlation of sensitivity and specificity, because, unlike univariate analyses, bivariate models do not transform pairs of sensitivity and specificity into single indicators as diagnostic accuracy \[[@CR19]\]. The overall pooling of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio was calculated using a random-effects model. Weighted summary receiver operating characteristic (SROC) analysis was implemented. The area under the curve (AUC) with 95% confidence interval (CI) was calculated. Bayes nomogram was also constructed to show the diagnostic accuracy of PPV in prediction of fluid responsiveness.

Heterogeneity across studies was assessed using the chi-square test and the Cochran *Q* statistic was calculated. The effect of heterogeneity was quantified using inconsistency (*I*^2^), which described the percentage of total variation attributed to heterogeneity rather than chance. *I*^2^ \> 50% would mean significant heterogeneity \[[@CR20]\]. A Galbraith plot was used to identify outliers. After removal of outliers, heterogeneity test was performed as mentioned before and AUC was also recalculated.

If significant heterogeneity was recorded, the proportion probably due to the threshold effect was evaluated using the Moses--Shapiro--Littenberg method \[[@CR21]\]. Another potential source of heterogeneity was investigated by meta-regression analysis if heterogeneity among studies could not be fully explained by the threshold effect. Publication bias was investigated using Deeks' funnel plot asymmetry test and the *P* value for the slope coefficient was reported \[[@CR22]\].

A subgroup analysis was carried out on different types of fluid that were used to assess fluid responsiveness. For studies reporting both the predictive value of PPV and stroke volume variation (SVV), the SROC AUC was calculated for both parameters.

Data were analyzed using STATA version 13.0 (Stata Corp LP, College Station, TX, USA) with the MIDAS module. Most data are expressed as value (95% CI). *P* \<0.05 was considered statistically significant.

Results {#Sec7}
=======

The process of the study search and inclusion is summarized in Figure [1](#Fig1){ref-type="fig"}. The 22 studies included in the final meta-analysis enrolled a total of 807 patients, with an average of 37 patients per study \[[@CR23]-[@CR44]\].Figure 1**Flowchart of study selection.** PPV, pulse pressure variation.

Characteristics of the 22 included studies are summarized in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. A total of 465 patients (58%) were responders to fluid challenge, ranging from 29 to 84% among 22 studies. Ten studies were performed in patients after cardiac surgery (*n* = 8) or other surgery (*n* = 2), while other studies were conducted in a mixed population of critically ill patients. Data on tidal volume, spontaneous breathing, and body weight were not available in some studies (Table [2](#Tab2){ref-type="table"}). Most studies did not report the respiratory rate (Table [2](#Tab2){ref-type="table"}). All of the included studies excluded patients with cardiac arrhythmia. With regards to fluid challenge, 6% hydroxyethyl starch (HES) was most commonly used (*n* = 13), followed by crystalloids (*n* = 6), other colloids (*n* = 2), and blood (*n* = 1). A volume ranging from 100 ml to 20 ml/kg body weight was infused within 1 minute up to 90 minutes. Cardiac output was monitored by means of PiCCO technology (*n* = 7), pulmonary artery catheter (*n* = 6), transesophageal/transthoracic echocardiography or Doppler measurements (*n* = 5), and other methods (*n* = 4). All studies except for two \[[@CR24],[@CR26]\] defined responders as patients whose stroke volume or cardiac output was increased by ≥15%.Table 1**Selected spectrum characteristics of included studiesOrderAuthorsYearSample sizeSettingAdmissionDiagnosis**1Michard and colleagues \[[@CR23]\]200040ICUMedicalSepsis/septic shock2Kramer and colleagues \[[@CR24]\]200421SICUSurgicalCardiac surgery3Feissel and colleagues \[[@CR25]\]200520^a^ICUMedicalSepsis/septic shock4Charron and colleagues \[[@CR26]\]200621ICUNANA5Monnet and colleagues \[[@CR27]\]200630MICUMedicalShock6Feissel and colleagues \[[@CR28]\]200723^b^MICUMedicalSepsis/septic shock7Wyffels and colleagues \[[@CR29]\]200732ICUSurgicalCardiac surgery8Auler and colleagues \[[@CR30]\]200859SICUSurgicalCardiac surgery9Monge Garcia and colleagues \[[@CR31]\]200938ICUNAShock10Vistisen and colleagues \[[@CR32]\]200923SICUSurgicalCardiac surgery11Loupec and colleagues \[[@CR33]\]201140SICUSurgical and medicalSurgery and septic shock12Biais and colleagues \[[@CR34]\]201235SICUSurgical and medicalVascular surgery, trauma, septic shock13Cecconi and colleagues \[[@CR35]\]201231ICUSurgicalHigh-risk surgery14Fellahi and colleagues \[[@CR36]\]201225SICUSurgicalCardiac surgery15Khwannimit and colleagues \[[@CR37]\]201242MICUMedicalSepsis/septic shock16Monnet and colleagues \[[@CR38]\]201226MICUMedicalShock17Monnet and colleagues \[[@CR39]\]201239MICUMedicalShock18Yazigi and colleagues \[[@CR40]\]201260SICUSurgicalCardiac surgery19Fischer and colleagues \[[@CR41]\]201337SICUSurgicalCardiac surgery20Fischer and colleagues \[[@CR42]\]201380SICUSurgicalCardiac surgery21Ishihara and colleagues \[[@CR43]\]201343ICUSurgicalNoncardiac surgery22Monnet and colleagues \[[@CR44]\]201335MICUMedicalShockMICU, medical intensive care unit; NA, not available; SICU, surgical intensive care unit. ^a^Twenty-two fluid challenges included. ^b^Twenty-eight fluid challenges included.Table 2**Selected methodological characteristics of included studiesOrderAuthorsYearVt (ml/kg)Body weightSpontaneous breathingRespiratory rate (times/minute)Cardiac arrhythmiaInfusion fluidInfusion volumeInfusion time (minutes)IndicesMethod for indicesCutoff value (%)**1Michard and colleagues \[[@CR23]\]20008 to 12NANoNANo6% HES500 ml30CIPAC152Kramer and colleagues \[[@CR24]\]20048 to 10NANoNANoBlood500 ml10 to 15COPAC123Feissel and colleagues \[[@CR25]\]20058 to 10NANoNANo6% HES7 ml/kg30CIEcho154Charron and colleagues \[[@CR26]\]20066 to 10NANo14 to 20No6% HES100 ml1SVEcho155Monnet and colleagues \[[@CR27]\]2006NANANo23 ± 5NoSaline500 ml10Aortic blood flowEsophageal Doppler156Feissel and colleagues \[[@CR28]\]20078 to 10NANoNANo6% HES8 ml/kg30CIEcho157Wyffels and colleagues \[[@CR29]\]20078 to 10NANoNANo6% HES500 ml20COPAC158Auler and colleagues \[[@CR30]\]20088NANoNANoLR20 ml/kg20CIPAC159Monge Garcia and colleagues \[[@CR31]\]20099IdealNo18 to 20No6% HES500 ml30SVFloTrac1510Vistisen and colleagues \[[@CR32]\]20098.1^a^PredictedNA14No6% HES500 ml45CIPAC1511Loupec and colleagues \[[@CR33]\]20118 to 10PredictedNoNANo6% HES^b^500 ml10COEcho1512Biais and colleagues \[[@CR34]\]20128 to 10PredictedNo16 ± 3^c^NoSaline500 ml15SVEcho1513Cecconi and colleagues \[[@CR35]\]20128IdealNo14NoColloid250 ml5COLiDCO plus1514Fellahi and colleagues \[[@CR36]\]2012NANANA12 ± 2No6% HES500 ml15CIPiCCO21515Khwannimit and colleagues \[[@CR37]\]2012≥ 8NANoNANo6% HES500 ml30SVFloTrac1516Monnet and colleagues \[[@CR38]\]20128.8^d^PredictedNoNANoSaline500 ml20CIPiCCO21517Monnet and colleagues \[[@CR39]\]20128.5^e^PredictedNoNANoSaline500 ml30CIPiCCO21518Yazigi and colleagues \[[@CR40]\]20128NANo12No6% HES7 ml/kg20SVPAC1519Fischer and colleagues \[[@CR41]\]20138.6NANANA^f^No6% HES500 ml15CIPiCCO21520Fischer and colleagues \[[@CR42]\]20138.2NANoNA^c^No6% HES500 ml15CIPiCCO21521Ishihara and colleagues \[[@CR43]\]2013≥ 8IdealNo12 to 15No10% dextran250 ml20CIPiCCO1522Monnet and colleagues \[[@CR44]\]20139PredictedNoNANoSaline500 ml30CIPiCCO215CI, cardiac index; CO, cardiac output; Echo, echocardiography; HES, hydroxyethyl starch; LR, Ringer's lactate; NA, not available; PAC, pulmonary artery catheter; SV, stroke volume; Vt, tidal volume. ^a^Mean Vt of 6.9 ml/kg actual body weight. ^b^Some patients evaluated with passive leg raising test. ^c^Heart rate/respiratory rate \>3.6. ^d^Only mean Vt \>8 ml/kg included. ^e^Mean Vt of 7.4 ml/kg for nonresponder. ^f^Heart rate/respiratory rate = 5.7.

Overall, the methodological quality was moderate (Additional file [1](#MOESM1){ref-type="media"}). Specifically, five out of 22 included studies reported enrollment of consecutive patients, and four studies reported no test review bias; that is, interpretation of the reference standard results without knowledge of the result of the index test, and *vice versa*.

The results for the diagnostic performance of the included studies and the method used to measure PPV are presented in Table [3](#Tab3){ref-type="table"}. The median threshold of PPV in predicting fluid responsiveness was 12% (interquartile range 10 to 13%).Table 3**Diagnostic performance of pulse pressure variation from included studiesOrderAuthorsYearThreshold** ^**a**^ **(%)tpfpfntnSens. (%)Spec. (%)Method used to measure PPV**1Michard and colleagues \[[@CR23]\]2000131511239496Waveform analysis with computer software2Kramer and colleagues \[[@CR24]\]2004116101410093Waveform analysis with computer software3Feissel and colleagues \[[@CR25]\]2005171102985100Waveform analysis with computer software4Charron and colleagues \[[@CR26]\]200610821108983Waveform analysis with computer software5Monnet and colleagues \[[@CR27]\]2006121412138893Waveform analysis with computer software6Feissel and colleagues \[[@CR28]\]2007121810910094Waveform analysis with computer software7Wyffels and colleagues \[[@CR29]\]200711.31911119592Analysis of printout curves8Auler and colleagues \[[@CR30]\]2008123811199795Waveform analysis with computer software9Monge Garcia and colleagues \[[@CR31]\]2009101811189595Waveform analysis with computer software10Vistisen and colleagues \[[@CR32]\]20096.5161159483Waveform analysis with computer software11Loupec and colleagues \[[@CR33]\]2011131922179089Waveform analysis with computer software12Biais and colleagues \[[@CR34]\]2012101722148988Waveform analysis with computer software13Cecconi and colleagues \[[@CR35]\]2012131052148374Waveform analysis with LiDCO14Fellahi and colleagues \[[@CR36]\]201210171438175Waveform analysis with PiCCO15Khwannimit and colleagues \[[@CR37]\]2012122034158383Direct analysis of monitored arterial tracing16Monnet and colleagues \[[@CR38]\]20121213021185100Waveform analysis with PiCCO17Monnet and colleagues \[[@CR39]\]2012101522208891Waveform analysis with PiCCO18Yazigi and colleagues \[[@CR40]\]201211.53358148074Direct analysis of monitored arterial tracing19Fischer and colleagues \[[@CR41]\]201316120151044100Waveform analysis with PiCCO20Fischer and colleagues \[[@CR42]\]20131436521186478Waveform analysis with PiCCO21Ishihara and colleagues \[[@CR43]\]20138.511612145071Waveform analysis with PiCCO22Monnet and colleagues \[[@CR44]\]2013151411199395Waveform analysis with PiCCOfn, false negative; fp, false positive; PPV, pulse pressure variation; sens., sensitivity; spec., specificity; tn, true negative; tp, true positive. ^a^Threshold used in studies to achieve corresponding sensitivity and specificity.

Pooled sensitivity was 0.88 (95% CI = 0.81 to 0.92) and pooled specificity was 0.89 (95% CI = 0.84 to 0.92) (Figure [2](#Fig2){ref-type="fig"}). PPV had an overall positive likelihood ratio of 7.7 (95% CI = 5.3 to 11.3), a negative likelihood ratio of 0.14 (95% CI = 0.08 to 0.23), and a diagnostic odds ratio of 56 (95% CI = 26 to 122). The SROC AUC was 0.94 (95% CI = 0.91 to 0.95) (Figure [3](#Fig3){ref-type="fig"}).Figure 2**Sensitivity and specificity of pulse pressure variation for prediction of fluid responsiveness.** CI, confidence interval.Figure 3**Summary receiver operating characteristic curve.** AUC, area under the curve; SENS, sensitivity; SPEC, specificity; SROC, summary receiver operating characteristic.

Moderate heterogeneity existed among the studies, with Cochran *Q* statistic of 4.681 (*P* = 0.042) and overall *I*^2^ for bivariate model of 60% (95% CI = 9 to 100). All of the heterogeneity (100%) was caused by the threshold effect. As a result, meta-regression analysis with the objective to explore the effects of potential covariates on the diagnostic performance of PPV was not performed. Four outliers were identified by means of a Galbraith plot (Figure [4](#Fig4){ref-type="fig"}) \[[@CR30],[@CR41]-[@CR43]\]. Heterogeneity became nonsignificant (Cochrane *Q* statistic = 0.146, *P* = 0.465) after removal of these four outliers, while the SROC AUC slightly improved (0.95, 95% CI = 0.93 to 0.97).Figure 4**Outliers identified using a Galbraith plot.**

We did not identify publication bias by Deeks' regression test of asymmetry; a statistically nonsignificant *P* value of 0.41 for the slope coefficient suggested symmetry in the data and a low likelihood of publication bias (Figure [5](#Fig5){ref-type="fig"}). Bayes nomogram showed moderate fine likelihood ratios and post-test probabilities (Figure [6](#Fig6){ref-type="fig"}).Figure 5**Deeks' funnel plot with superimposed regression line.** *P*value for slope coefficient is 0.41, which is greater than 0.05, suggesting the symmetry of the studies and the low likelihood of publication bias.Figure 6**Bayes nomogram of pulse pressure variation for prediction of fluid responsiveness.**

For studies using HES or saline to assess fluid responsiveness, the SROC AUC of PPV was 0.92 (95% CI = 0.89 to 0.94) and 0.96 (95% CI = 0.94 to 0.98), respectively. Nine studies reported the predictive value of both PPV and SVV, and both SROC AUCs were 0.90 (95% CI = 0.87 to 0.93) (Additional file [2](#MOESM2){ref-type="media"}).

Discussion {#Sec8}
==========

The major finding of this systematic review and meta-analysis is that PPV during controlled mechanical ventilation with tidal volume \>8 ml/kg is an accurate predictor of fluid responsiveness in critically ill patients, with sensitivity of 0.88 (95% CI = 0.81 to 0.92), specificity of 0.89 (95% CI = 0.84 to 0.92), and SROC AUC of 0.94 (95% CI = 0.91 to 0.95).

In a meta-analysis of the literature to determine the ability of PPV, systolic pressure variation, and SVV to predict fluid responsiveness, Marik and colleagues included 29 studies enrolling a total of 685 patients and reported the pooled ROC AUC for PPV as 0.94 (95% CI = 0.93 to 0.95) \[[@CR11]\], which is in accordance with our findings. Very recently, Hong and colleagues published another meta-analysis involving 865 mechanically ventilated patients from 19 studies, to evaluate the value of both SVV and PPV in predicting fluid responsiveness \[[@CR45]\]. These authors reported a significantly lower pooled ROC AUC for PPV (0.88, 95% CI = 0.84 to 0.92). However, there are several major differences between these two meta-analyses and our study. First, most of the included studies in the above two meta-analyses (12 out of 18 studies \[[@CR11]\] and 12 out of 19 studies \[[@CR45]\], respectively) were conducted in perioperative settings (that is, before or after induction of anesthesia) or during surgery. In contrast, we limited our meta-analysis to those studies in critically ill patients in the ICU. Perioperative patients differ from critically ill patients in the ICU with regards to age, comorbidities, severity of illness, complications, and clinical outcome. Moreover, the predictive ability of PPV might be compromised in open chest conditions, due to inaccurate reflection of phasic changes in preload (and hence stroke volume), increased aortic impedance (and subsequent changes in the relationship between stroke volume and pulse pressure), as well as less pronounced cyclic changes in intrathoracic pressure \[[@CR41],[@CR46]\]. Second, we adopted very strict inclusion and exclusion criteria in our meta-analysis. We excluded studies with a tidal volume \<8 ml/kg. But one study \[[@CR47]\] from Marik and colleagues' review and one study \[[@CR48]\] from Hong and colleagues' review included tidal volume \<7 ml/kg. We excluded two studies \[[@CR49],[@CR50]\] included by Marik and colleagues because they reported PPV in fewer than 10 patients so that the 2 × 2 contingency table could not be generated. In addition, two studies with contradicting information without clarification from the authors were also excluded \[[@CR51],[@CR52]\]. Third, Marik and colleagues did not find any heterogeneity using the Cochran *Q* statistic. Despite the fact that two parameters were meta-analyzed with only one Cochran's *Q* statistic reported, Hong and colleagues considered between-study heterogeneity low enough to consider the study population as statistically homogeneous for applying appropriate AUC statistics. We reported borderline heterogeneity in our studies. Possible reasons might include the different studies involved in the meta-analysis (as mentioned above) as well as different statistical models used. We found that the heterogeneity observed in our meta-analysis could be fully explained by the threshold effect, which had not been investigated in the previous meta-analyses. The threshold effect is one of main causes of heterogeneity in test accuracy studies. It arises owing to different thresholds or cutoff values used in different studies to determine a positive (or negative) test result. The median threshold level for PPV to predict fluid responsiveness in our meta-analysis was 12% (interquartile range 10 to 13%) with a sensitivity of 0.88 and a specificity of 0.89. The bottom line is that we believe it would be reasonable to postulate that PPV \>13% implied fluid responsiveness, while PPV \<10% indicated fluid unresponsiveness.

To explore other potential sources of heterogeneity, we focused on the studies with the lowest sensitivity value and Youden index (sensitivity + specificity −1) (Figure [3](#Fig3){ref-type="fig"}). These were also three of the four studies identified using a Galbraith plot (Figure [4](#Fig4){ref-type="fig"}). Two of the studies were carried out similarly by the same first author \[[@CR41],[@CR42]\]. In the study with larger sample size, Fischer and colleagues found that one-third of the patients had right ventricular dysfunction and 34% of ICU patients with PPV \>12% were fluid unresponsive \[[@CR42]\]. Wyler von Ballmoos and colleagues supported that right ventricular dysfunction led to poor response to fluids in patients with increased pulmonary artery pressure \[[@CR53]\]. Similar to Fischer and colleagues' study, Biais and colleagues evaluated right ventricular function using echocardiography and excluded patients with right ventricular dysfunction from their study \[[@CR34]\]. Ishihara and colleagues examined the predictive value of PPV in patients after open-chest abdominothoracic esophagectomy with extensive resection of lymph nodes \[[@CR43]\]. They postulated that extensive alteration of thoracic structure might change the cyclic variation of intrathoracic pressure, leading to a modified heart--lung interaction. Postoperative left pleural effusion was common in their patients. Right ventricular dysfunction and extensive alteration of thoracic structure will limit the use of PPV to predict fluid responsiveness.

In the OPTIMISE study, patients in the cardiac output-guided hemodynamic therapy algorithm group were given fluid challenges to reach maximal stroke volume, but no difference of a composite outcome of complications or 30-day mortality was found between the trial group and the usual care group in patients undergoing major gastrointestinal surgery \[[@CR6]\]. The POEMAS Study found similar results \[[@CR54]\]. However, fluid responsiveness does not necessarily mean that the patients require fluid resuscitation, as long as there are no signs of tissue hypoperfusion \[[@CR55]\]. The cardiac functions of critically ill patients and their disease status are dynamic, while the adequacy of tissue perfusion should be the focus \[[@CR56]\].

Our study is subject to some limitations. First, sample sizes of the included studies were small. However, even under this condition a meta-analysis still provides valuable information on the diagnostic accuracy until proven otherwise by larger or better-conducted studies \[[@CR57]\]. Second, different instruments (pulmonary artery catheter, echocardiography, PiCCO, and so forth) and indices (cardiac output/index, stroke volume, and so forth) were used to evaluate fluid responsiveness, and different methods were used to measure PPV. Nonetheless, this reflects the real situation in a contemporary ICU. It is also convenient to evaluate PPV by directly analyzing monitored arterial tracing or printout curves \[[@CR29],[@CR37],[@CR40]\], which means PPV can be evaluated repeatedly and regularly, and with computer software and waveform analysis can be monitored continuously. This is attractive to intensivists who have to titrate fluid resuscitation in mechanically ventilated patients almost every day. Nevertheless, it is important that elimination or minimization of fluid responsiveness, including PPV, should never be the only goal of fluid therapy. Third, we excluded studies in which patients were ventilated using low tidal volumes, which is the commonly accepted ventilation strategy in patients with acute respiratory distress syndrome. Because most studies showed that although better than conventional static parameters, PPV had limited value in predicting fluid responsiveness in these patients \[[@CR52],[@CR58]-[@CR64]\]. This was probably because, with low tidal volume ventilation, the cyclic changes in intrathoracic pressures were not significant enough to induce preload variations \[[@CR58]\]. Huang and colleagues and Freitas and colleagues, however, found that PPV accurately predicted fluid responsiveness in patients ventilated with a tidal volume of 6 ml/kg \[[@CR65],[@CR66]\]. They attributed the discrepancy to higher positive end-expiratory pressure levels, which enhanced the cyclic changes in pleural pressures. More trials concerning the effect of positive end-expiratory pressure on PPV are needed in the future. Before more data are presented, a temporary change of ventilator parameters maybe used to evaluate PPV at a larger tidal volume, as demonstrated by Freitas and colleagues \[[@CR66]\]. Fourth, more than one-half of the included studies used HES. Nowadays, however, fewer patients receive HES with consideration of its detrimental effect on the kidney, as in the OPTIMISE study \[[@CR6]\]. However, we performed a subgroup analysis and found that the SROC AUC of PPV was 0.92 (95% CI = 0.89 to 0.94) for studies using HES and 0.96 (95% CI = 0.94 to 0.98) for studies using saline, suggesting that the choice of fluid does not influence the predictive value of PPV. Fifth, ICU patients are often with conditions precluding the use of PPV. In their 1-day prospective observational study, Mahjoub and colleagues found that only 15 out of 79 (19%) patients used PPV to measure fluid responsiveness \[[@CR67]\]. However, as advocated by Teboul and Monnet, other fluid responsiveness tests, such as passive leg raising test or end-expiratory occlusion test, could be used when PPV was not available \[[@CR68]\]. Measurement of SVV is also influenced, as that of PPV, by the presence of cardiac arrhythmia or spontaneous breathing, as well as low tidal volume ventilation, while it requires much more complicated devices than PPV. Two meta-analyses suggested that both SVV and PPV are accurate predictors of fluid responsiveness in hemodynamically unstable patients under controlled mechanical ventilation \[[@CR11],[@CR45]\]. With studies reporting both PPV and SVV included in our meta-analysis, we found similar results. Sixth, only Biais and colleagues and Fischer and colleagues evaluated right ventricular function using echocardiography, and only Biais and colleagues excluded patients with right ventricular dysfunction from their study \[[@CR34],[@CR42]\].

Conclusions {#Sec9}
===========

PPV is an accurate predictor of fluid responsiveness in critically ill patients passively ventilated with tidal volume \>8 ml/kg and without cardiac arrhythmia.

Key messages {#Sec10}
============

A significant threshold effect existed while using PPV to determine a responder (or nonresponder) to volume expansion.PPV is an accurate predictor of fluid responsiveness in critically ill patients ventilated with relative large tidal volume and without spontaneous breathing and cardiac arrhythmia.

Additional files {#Sec11}
================

Additional file 1: Table S1.Presenting a summary of QUADAS-2 quality assessment. We tailored QUADAS-2 to our review by omitting the second signalling question in domain 2′: If a threshold was used, was it pre-specified?'. Reasons for classifying high risk or unclear risk of bias are provided in footnotes for each study.Additional file 2: Table S2.Presenting the diagnostic performance of PPV and SVV from included studies reporting both parameters.
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